Targeted Gene Therapy of Ovarian Cancer Using an Ovarian-Specific Promoter

This publication has 11 references indexed in Scilit:

• Transcriptional Targeting for Ovarian Cancer Gene Therapy
  Gynecologic Oncology, 2001
• Use of a Surrogate Marker (Human Secreted Alkaline Phosphatase) to Monitor in Vivo Tumor Growth and Anticancer Drug Efficacy in Ovarian Cancer Xenografts
  Gynecologic Oncology, 2000
• Transcriptional analysis of human survivin gene expression
  Biochemical Journal, 1999
• Analysis of the human carcinoembryonic antigen promoter core region in colorectal carcinoma-selective cytosine deaminase gene therapy
  Cancer Gene Therapy, 1999
• Molecular chemotherapy for breast cancer.
  Drugs & Aging, 1999
• Gene Therapy for Lung Cancer--an Application for Cationic Lipid-Mediated Gene Delivery?
  JNCI Journal of the National Cancer Institute, 1998
• In vitro expression of the diphtheria toxin A-chain gene under the control of human chorionic gonadotropin gene promoters as a means of directing toxicity to ovarian cancer cell lines
  American Journal of Obstetrics and Gynecology, 1997
• Gene Therapy for Peritoneal Dissemination of Pancreatic Cancer by Liposome-Mediated Transfer of Herpes Simplex Virus Thymidine Kinase Gene
  Human Gene Therapy, 1997
• Retroviral-like sequences specifically expressed in the rat ovary detect genetic differences between normal and transformed rat ovarian surface epithelial cells.
  Endocrinology, 1995
• Nonviral Gene Therapy: The Promise of Genes as Pharmaceutical Products
  Human Gene Therapy, 1995